Goodrx Holdings earnings were $16.2M for the trailing 12 months ending Jun 30, 2026, with -44.4% growth year over year. The latest GDRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of $8.5M, up 630.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GDRX reported annual earnings of $30.4M, with 85.7% growth.
GDRX past earnings growth
How has GDRX's earnings growth performed historically?
What were Goodrx Holdings's earnings last quarter?
On GDRX's earnings call on Aug 5, 2026, Goodrx Holdings (NASDAQ: GDRX) reported Q2 2026 earnings per share (EPS) of $0.03, up 25% year over year. Total GDRX earnings for the quarter were $8.54 million. In the same quarter last year, Goodrx Holdings's earnings per share (EPS) was $0.04.
As of the last Goodrx Holdings earnings report, Goodrx Holdings is currently profitable. Goodrx Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $16.25 million, a 53.04% decrease year over year.
What was GDRX's earnings growth in the past year?
As of Goodrx Holdings's earnings date in Aug 5, 2026, Goodrx Holdings's earnings has grown -44.44% year over year. This is 105.61 percentage points lower than the US Health Information Services industry earnings growth rate of 61.16%. GDRX earnings in the past year totalled $16.25 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.